Skip to main content
. 2021 May 31;11:11350. doi: 10.1038/s41598-021-90879-z

Table 1.

Baseline clinical characteristics.

P-FD group F-FD group P-value
Number of subjects 65 64
Male 28 (43.1%) 24 (37.5%) 0.5914
Age (years) 56.9 (11.0) 56.6 (12.0) 0.8831
Body weight (kg) 77.0 (12.9) 76.6 (17.7) 0.8692
BMI (kg/m2) 29.4 (4.4) 29.8 (6.3) 0.6897
Past maximum weight (kg) 80.7 (12.8) 81.3 (17.6) 0.8315
Waist circumference (cm) 100.4 (11.3) 99.1 (11.9) 0.5369
Duration of DM (years) 7.5 (6.0) 9.1 (7.9) 0.2317
HbA1c (%) 7.4 (0.4) 7.4 (0.5) 0.8889
HbA1c (mmol/mol) 57.2 (4.6) 57.1 (5.1)
Fasting glucose (mmol/l) 8.2 (1.7) 8.3 (2.0) 0.8758
eGFR (mL/min/1.73 m2) 85.6 (18.9) 85.9 (23.3) 0.9504
sBP (mmHg) 133.2 (16.8) 133.9 (13.7) 0.8133
dBP (mmHg) 80.2 (10.9) 79.1 (8.9) 0.5408
Heart rate (bpm) 77.5 (14.1) 78.0 (14.5) 0.8681
History of hypertension 36 (55.3%) 40 (62.5%) 0.4755
History of dyslipidemia 51 (78.5%) 48 (75.0%) 0.6810

P-FD protein-rich formula diet, F-FD fat-rich formula diet, BMI body mass index, eGFR estimated glomerular filtration rate, sBP systolic blood pressure, dBP diastolic blood pressure. Data are expressed as n (%) or mean (SD).